Stay updated on SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.

Latest updates to the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record page now shows a 403 Forbidden error with a minimal header and footer, replacing the usual content. This indicates access to the page is restricted.SummaryDifference20%

- Check56 days agoChange DetectedThe page now includes a 2023 NIH grant/contract funding note and the page revision has been updated to v3.6.6, with the previous v3.6.5 revision removed. These are registrar housekeeping updates reflecting funding attribution and versioning rather than changes to the study content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating an administrative update to the site’s content management system. This update does not change the study details presented on the page.SummaryDifference0.0%

- Check92 days agoChange DetectedThe study's location list expanded to 62 sites, adding Gustave Roussy Institute in Villejuif, France, and a Beijing, China site. Paris and Beijing addresses were updated to reflect new postal codes.SummaryDifference0.7%

Stay in the know with updates to SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.